TissGDB
Tissglogo

Home

Download

 Statistics

 Landscape

Help

Contact

Bioinformatics and Systems Medicine Laboratory Bioinformatics and Systems Medicine Laboratory

bullet point

TissGeneSummary

bullet point

TissGeneExp

bullet point

TissGene-miRNA

bullet point

TissGeneMut: TissGeneSNV, TissGeneCNV, and TissGeneFusions

bullet point

TissGeneNet

bullet point

TissGeneProg

bullet point

TissGeneClin: TissGeneDrug and TissGeneDisease

TissGeneSummary for SLC2A2
check button Gene summary
Basic gene informationGene symbolSLC2A2
Gene namesolute carrier family 2 (facilitated glucose transporter), member 2
SynonymsGLUT2
CytomapUCSC genome browser: 3q26.1-q26.2
Type of geneprotein-coding
RefGenesNM_000340.1,
NM_001278658.1,NM_001278659.1,
Descriptionglucose transporter type 2, liversolute carrier family 2, facilitated glucose transporter member 2
Modification date20141207
dbXrefs MIM : 138160
HGNC : HGNC
Ensembl : ENSG00000163581
HPRD : 00685
Vega : OTTHUMG00000158997
ProteinUniProt:
go to UniProt's Cross Reference DB Table
ExpressionCleanEX: HS_SLC2A2
BioGPS: 6514
PathwayNCI Pathway Interaction Database: SLC2A2
KEGG: SLC2A2
REACTOME: SLC2A2
Pathway Commons: SLC2A2
ContextiHOP: SLC2A2
ligand binding site mutation search in PubMed: SLC2A2
UCL Cancer Institute: SLC2A2
Assigned class in TissGDB*B
Included tissue-specific gene expression resourcesHPA,TiGER,GTEx
Specific-tissues in normal samples (assigned by TissGDB using HPA, TiGER, and GTEx)KidneyLiver
Cancer types related to the specific-tissues in cancer samples (assigned by TissGDB using TCGA)KIRC,KIRP,KICHLIHC
Reference showing the relevant tissue of SLC2A2
Description by TissGene annotationsSignificant down-regulated DEG
TissgsKTS
CNV lost TissGeneKTS
* Class A consists of genes with literature evidence and is part of the cTissGenes. Class B consists of only cTissGenes without additional evidence. The remaining genes belong to Class C.

check button Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez
GO IDGO termPubMed ID


Top
TissGeneExp for SLC2A2

check button Gene expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1))
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
gene exp


check button Gene isoform expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1))
(TCGA pan-cancer tcga_rsem_isoform_tpm, version 2016-09-01)
gene isoform exp


check button Gene expressions across normal tissues of GTEx data
(GTEx GTEx_Analysis_v6_RNA-seq_RNA-SeQCv1.1.8_gene_rpkm.gct)
- Here, we shows the matched tissue types only among our 28 cancer types.
normal gene exp


check button Different expressions across 14 cancer types with more than 10 samples between matched tumors and normals (X-axis: cancer type and Y-axis: log2(norm_counts+1))
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
DEG exp

- Significantly differentially expressed cancer types and information. (|Fold change|>1 and FDR<0.05)
Cancer typeMean(exp) in tumorMean(exp) in matched normalLog2FCP-val.FDR
KICH-0.7789960984.577075902-5.3560721.84E-089.41E-08
LIHC10.675897913.0134339-2.3375362.59E-061.27E-05
KIRC7.5876108465.5526247352.0349861117.92E-050.000168714


Top
TissGene-miRNA for SLC2A2

check button Significantly anti-correlated miRNAs of TissGene across 28 cancer types
(Gene-miRNA relations from TargetScanHuman Relsease 7.1, Conserved_Site_Context_Scores.txt.zip, 06.01.2016)
(TCGA IlluminaHiSeq_miRNASeq, log2(RPM+1) data, version 2016-11-21)
(TCGA IlluminaHiSeq_RNASeqV2, log2(normalized_count+1) data, version 2016-08-16)
(Spearman’s Rank Correlation (p-value<0.05 and coefficient<-0.25))
Cancer typemiRNA idmiRNA accessionP-val.Coeff.# samples


Top
TissGeneMut for SLC2A2
TissGeneSNV for SLC2A2

check button nsSNV counts per each loci.
Different colors of circles represent different cancer types. Circle size denotes number of samples.
(TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25)

* Click on the image to enlarge it in a new window.
SNV lollipop
bullet point


check button Somatic nucleotide variants of TissGene across 28 cancer types
(X-axis: cancer type and Y-axis: % of mutated samples)
The numbers in parentheses are numbers of samples with mutation (nsSNVs).
(TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25)
SNV distribution

- nsSNVs sorted by frequency.
AAchangeCancer type# samples
p.F393LUCEC2
p.L134MCOAD1
p.P463LOV1
p.F427SLUSC1
p.Q429ELUAD1
p.A183TSTAD1
p.G462ESKCM1
p.G108ELUAD1
p.Q204XSKCM1
p.R53QUCEC1
p.D51NSKCM1
p.L222FSTAD1
p.G265RSKCM1
p.R53QSKCM1
p.R365*STAD1
p.P431SSKCM1
p.S374RUCEC1
p.L140VHNSC1
p.S442ILUAD1
p.A333TBLCA1
p.Y398FHNSC1
p.M401ISKCM1
p.G430ESKCM1
p.V137FLUAD1
p.F481LUCEC1
p.F469VUCEC1
p.A183THNSC1
p.Q315HSKCM1
p.S145LSKCM1
p.K77QUCEC1
p.F113LUCEC1
p.S317FKIRP1
p.M276IBLCA1
p.A195TSTAD1
p.Q204*SKCM1
p.E83KESCA1
p.H151DBLCA1
p.D272YUCEC1
p.S21YLUAD1
p.F481CCHOL1
p.V197IHNSC1
p.T332MLUSC1
p.R365XSTAD1
p.Q302ESARC1
p.F393LPAAD1
p.A156DKIRP1
p.E178KBLCA1
p.E275KSKCM1
p.D51GLUSC1
p.L46SKIRP1
p.I176TSTAD1
p.G226VLUAD1
p.R366SHNSC1
p.E514KHNSC1
p.I70LLIHC1
p.F22YCOAD1
p.R365*UCEC1
p.G471ESKCM1
p.V197IOV1
p.M401ICESC1
p.R301*PAAD1
p.G489ESKCM1
p.G177SSKCM1
p.E85DUCEC1
p.A229VSARC1
p.L92VLIHC1
p.G265EHNSC1
p.G223VUCEC1
p.E252KBLCA1
p.V513IBLCA1
p.Y245*UCEC1
p.Y300HLIHC1
p.I220VSTAD1


Top
TissGeneCNV for SLC2A2

check button Copy number variations of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of CNV samples)
(TCGA Gistic2_CopyNumber_Gistic2_all_data_by_genes, Gistic2 copy number data, version 2016-08-16)
CNV


Top
TissGeneFusions for SLC2A2

check button Fusion genes including TissGene
(ChimerDB 3.0, 2016-12-01 and TCGA fusion Portal 2015-12-01)
DatabaseSrcCancer typeSampleFusion geneORF5'-gene BP3'-gene BP


Top
TissGeneNet for SLC2A2

check button Co-expressed gene networks based on protein-protein interaction data (CePIN)
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
(PINA2 ppi data)
BRCA (tumor)BRCA (normal)
SLC2A2, KPNA2, PRKACA, HNF1A, PDX1 (tumor)SLC2A2, KPNA2, PRKACA, HNF1A, PDX1 (normal)
bullet pointbullet point
COAD (tumor)COAD (normal)
SLC2A2, KPNA2, PRKACA, HNF1A, PDX1 (tumor)SLC2A2, KPNA2, PRKACA, HNF1A, PDX1 (normal)
bullet pointbullet point
HNSC (tumor)HNSC (normal)
SLC2A2, KPNA2, PRKACA, HNF1A, PDX1 (tumor)SLC2A2, KPNA2, PRKACA, HNF1A, PDX1 (normal)
bullet pointbullet point
KICH (tumor)KICH (normal)
SLC2A2, KPNA2, PRKACA, HNF1A, PDX1 (tumor)SLC2A2, KPNA2, PRKACA, HNF1A, PDX1 (normal)
bullet pointbullet point
KIRC (tumor)KIRC (normal)
SLC2A2, KPNA2, PRKACA, HNF1A, PDX1 (tumor)SLC2A2, KPNA2, PRKACA, HNF1A, PDX1 (normal)
bullet pointbullet point
KIRP (tumor)KIRP (normal)
SLC2A2, KPNA2, PRKACA, HNF1A, PDX1 (tumor)SLC2A2, KPNA2, PRKACA, HNF1A, PDX1 (normal)
bullet pointbullet point
LIHC (tumor)LIHC (normal)
SLC2A2, KPNA2, PRKACA, HNF1A, PDX1 (tumor)SLC2A2, KPNA2, PRKACA, HNF1A, PDX1 (normal)
bullet pointbullet point
LUAD (tumor)LUAD (normal)
SLC2A2, KPNA2, PRKACA, HNF1A, PDX1 (tumor)SLC2A2, KPNA2, PRKACA, HNF1A, PDX1 (normal)
bullet pointbullet point
LUSC (tumor)LUSC (normal)
SLC2A2, KPNA2, PRKACA, HNF1A, PDX1 (tumor)SLC2A2, KPNA2, PRKACA, HNF1A, PDX1 (normal)
bullet pointbullet point
PRAD (tumor)PRAD (normal)
SLC2A2, KPNA2, PRKACA, HNF1A, PDX1 (tumor)SLC2A2, KPNA2, PRKACA, HNF1A, PDX1 (normal)
bullet pointbullet point
STAD (tumor)STAD (normal)
SLC2A2, KPNA2, PRKACA, HNF1A, PDX1 (tumor)SLC2A2, KPNA2, PRKACA, HNF1A, PDX1 (normal)
bullet pointbullet point
THCA (tumor)THCA (normal)
SLC2A2, KPNA2, PRKACA, HNF1A, PDX1 (tumor)SLC2A2, KPNA2, PRKACA, HNF1A, PDX1 (normal)
bullet pointbullet point


Top
TissGeneProg for SLC2A2

check button Kaplan-Meier plots with logrank tests of overall survival (OS) using 28 cancer types
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
(TCGA clinicalMatrix, phenotype data, version 2016-04-27)

* Click on the image to enlarge it in a new window.
survival 1

check button Kaplan-Meier plots with logrank test of relapse free survival (RFS) using 28 cancer types
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
(TCGA clinicalMatrix, phenotype data, version 2016-04-27)

* Click on the image enlarge it in a new window.
survival 2

check button Forest plot of Cox proportional hazard ratio (HR) and 95% CI of overall survival (OS) using 28 cancer types
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
(TCGA clinicalMatrix, phenotype data, version 2016-04-27)

* Click on the image enlarge it in a new window.
survival 3

check button Forest plot of Cox proportional hazard ratio (HR) and 95% CI of relapse free survival (RFS) using 28 cancer types
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
(TCGA clinicalMatrix, phenotype data, version 2016-04-27)

* Click on the image enlarge it in a new window.
survival 4

Top
TissGeneClin for SLC2A2
TissGeneDrug for SLC2A2

check button Drug information targeting TissGene
(DrugBank Version 5.0.6, 2017-04-01)
DrugBank IDDrug nameDrug activityDrug typeDrug status
DB00428StreptozocinLigandSmall moleculeApproved


Top
TissGeneDisease for SLC2A2

check button Disease information associated with TissGene
(DisGeNet, 2016-06-01)
Disease IDDisease name# pubmedsSource
umls:C0011860Diabetes Mellitus, Non-Insulin-Dependent32BeFree,CLINVAR,CTD_human,GAD,LHGDN,MGD
umls:C3495427Fanconi-Bickel Syndrome26BeFree,CLINVAR,ORPHANET,UNIPROT
umls:C0011849Diabetes Mellitus12BeFree
umls:C0011847Diabetes11BeFree
umls:C0020456Hyperglycemia5BeFree
umls:C0028754Obesity4BeFree
umls:C0158981Neonatal diabetes mellitus4BeFree
umls:C0271650Impaired glucose tolerance4BeFree
umls:C0007222Cardiovascular Diseases3BeFree
umls:C0016952Galactosemias3BeFree
umls:C0011853Diabetes Mellitus, Experimental2CTD_human,RGD
umls:C0011854Diabetes Mellitus, Insulin-Dependent2BeFree
umls:C0011881Diabetic Nephropathy2BeFree,GAD
umls:C0017919Glycogen Storage Disease2BeFree
umls:C0020615Hypoglycemia2BeFree
umls:C0022658Kidney Diseases2BeFree
umls:C0149782Squamous cell carcinoma of lung2BeFree
umls:C2239176Liver carcinoma2BeFree,CTD_human
umls:C0004153Atherosclerosis1GAD
umls:C0006142Malignant neoplasm of breast1BeFree
umls:C0007102Malignant tumor of colon1BeFree
umls:C0007137Squamous cell carcinoma1BeFree
umls:C0011253Delusions1BeFree
umls:C0015624Fanconi Syndrome1CTD_human
umls:C0015695Fatty Liver1CTD_human
umls:C0017980Glycosuria, Renal1BeFree
umls:C0019209Hepatomegaly1BeFree
umls:C0020503Hyperparathyroidism, Secondary1GAD
umls:C0021670insulinoma1BeFree
umls:C0032000Pituitary Adenoma1BeFree
umls:C0032002Pituitary Diseases1BeFree
umls:C0032019Pituitary Neoplasms1BeFree
umls:C0042769Virus Diseases1BeFree
umls:C0079731B-Cell Lymphomas1BeFree
umls:C0221032Familial generalized lipodystrophy1BeFree
umls:C0242363Islet Cell Tumor1BeFree
umls:C0268186Congenital glucose-galactose malabsorption1BeFree
umls:C0268731Renal glomerular disease1BeFree
umls:C0342273Transient neonatal diabetes mellitus1BeFree
umls:C0678222Breast Carcinoma1BeFree
umls:C0699790Colon Carcinoma1BeFree
umls:C0858600Taste sweet1BeFree
umls:C1458155Mammary Neoplasms1CTD_human
umls:C1833104DIABETES MELLITUS, PERMANENT NEONATAL1BeFree
umls:C3245525Familial renal glucosuria1BeFree